Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer. (Q40723187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Eshetu G. Atenafu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Anthony M Joshua

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

12

I F Tannock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

A J Templeton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Francisco Vera-Badillo

7

object named as

F Vera-Badillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

R Leibowitz-Amit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Omlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Pezaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D Keizman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J-A Seah

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J J Knox

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S S Sridhar

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J S de Bono

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

23 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

657-662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

Alpha emitter radium-223 and survival in metastatic prostate cancer

6 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Immunomonitoring and prognostic relevance of neutrophils in clinical trials.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Abiraterone in metastatic prostate cancer without previous chemotherapy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Protumor and antitumor functions of neutrophil granulocytes

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Increased survival with enzalutamide in prostate cancer after chemotherapy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Abiraterone and increased survival in metastatic prostate cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Hallmarks of Cancer: The Next Generation

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Inflammation and cancer: back to Virchow?

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433513

Prednisone-induced leucocytosis in nephrotic syndrome

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/ANNONC/MDT581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458472%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

24458472

1 reference